Dysglycemia and a History of Reproductive Risk Factors

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2008 May 7

PMID 18458144

Citations 10

Authors

Sarah D McDonald

Salim Yusuf

Patrick Sheridan

Sonia S Anand

Hertzel C Gerstein

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to identify reproductive risk factors associated with dysglycemia (diabetes, impaired glucose tolerance, and impaired fasting glucose) in a contemporary multiethnic population.

Research Design And Methods: We studied 14,661 women screened with an oral glucose tolerance test for the Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) trial. Reproductive risk factors were compared in normoglycemic and dysglycemic women.

Results: Dysglycemia was significantly associated with the number of children born (odds ratio 1.03 per child [95% CI 1.01-1.05]), age (1.05 per year [1.04-1.05]), non-European ancestry (1.09 [1.01-1.17]), preeclampsia/eclampsia (1.14 [1.02-1.27]), irregular periods (1.21 [1.07-1.36]), and gestational diabetes mellitus (GDM) (1.53 [1.35-1.74]). The relationship between GDM and dysglycemia did not differ across BMI tertiles (P = 0.84) nor did the relationships of other risk factors.

Conclusions: Reproductive factors, particularly GDM, are associated with dysglycemia in middle-aged women from many ethnicities. Reproductive factors can be used to counsel young women about their future risk of dysglycemia, whereas in middle age they may help screen for dysglycemia.

Citing Articles

Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.

Rokhman M, Arifin B, Zulkarnain Z, Satibi S, Perwitasari D, Boersma C PLoS One. 2022; 17(7):e0269853.

PMID: 35862370 PMC: 9302803. DOI: 10.1371/journal.pone.0269853.

Pregnancy complications and later vascular ultrasound measures: A cohort study.

Harville E, Juonala M, Viikari J, Kahonen M, Raitakari O Pregnancy Hypertens. 2017; 10:171-176.

PMID: 29153673 PMC: 5726803. DOI: 10.1016/j.preghy.2017.08.001.

Childhood Risk Factors and Pregnancy-Induced Hypertension: The Bogalusa Heart Study.

Li S, Xiong X, Harville E, Zhang T, Sun D, Fernandez C Am J Hypertens. 2016; 29(10):1206-11.

PMID: 27251339 PMC: 5018998. DOI: 10.1093/ajh/hpw057.

Disparities in Prenatal Care Utilization Among U.S. Versus Foreign-Born Women with Chronic Conditions.

Goldfarb S, Smith W, Epstein A, Burrows S, Wingate M J Immigr Minor Health. 2016; 19(6):1263-1270.

PMID: 27221086 DOI: 10.1007/s10903-016-0435-x.

Parity and Risk of Coronary Heart Disease in Middle-aged and Older Chinese Women.

Shen L, Wu J, Xu G, Song L, Yang S, Yuan J Sci Rep. 2015; 5:16834.

PMID: 26607032 PMC: 4660373. DOI: 10.1038/srep16834.

References

Bosch J, Yusuf S, Gerstein H, Pogue J, Sheridan P, Dagenais G . Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006; 355(15):1551-62. DOI: 10.1056/NEJMoa065061. View

Manson J, Rimm E, Colditz G, Stampfer M, Willett W, Arky R . Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med. 1992; 93(1):13-8. DOI: 10.1016/0002-9343(92)90674-z. View

OSullivan J . Diabetes mellitus after GDM. Diabetes. 1991; 40 Suppl 2:131-5. DOI: 10.2337/diab.40.2.s131. View

Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N . Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006; 368(9541):1096-105. DOI: 10.1016/S0140-6736(06)69420-8. View

Dalfra M, Lapolla A, Masin M, Giglia G, Dalla Barba B, Toniato R . Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab. 2002; 27(6):675-80. View

Harris M, Eastman R, Cowie C, Flegal K, Eberhardt M . Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care. 1997; 20(12):1859-62. DOI: 10.2337/diacare.20.12.1859. View

Pallardo L, Herranz L, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Janez M . Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care. 2003; 26(8):2318-22. DOI: 10.2337/diacare.26.8.2318. View

Williams D . Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003; 15(6):465-71. DOI: 10.1097/00001703-200312000-00002. View

Kaaja R, Laivuori H, Laakso M, Tikkanen M, Ylikorkala O . Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999; 48(7):892-6. DOI: 10.1016/s0026-0495(99)90225-1. View

10.

Sibai B, Gonzalez-Ruiz A . Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986; 155(5):1011-6. DOI: 10.1016/0002-9378(86)90336-4. View

11.

Lauenborg J, Hansen T, Jensen D, Vestergaard H, Molsted-Pedersen L, Hornnes P . Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care. 2004; 27(5):1194-9. DOI: 10.2337/diacare.27.5.1194. View

12.

Collins V, Dowse G, Zimmet P . Evidence against association between parity and NIDDM from five population groups. Diabetes Care. 1991; 14(11):975-81. DOI: 10.2337/diacare.14.11.975. View

13.

DeUgarte C, Bartolucci A, Azziz R . Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005; 83(5):1454-60. DOI: 10.1016/j.fertnstert.2004.11.070. View

14.

Diamanti-Kandarakis E, Papavassiliou A . Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006; 12(7):324-32. DOI: 10.1016/j.molmed.2006.05.006. View

15.

Fuh M, Yin C, Pei D, Sheu W, Jeng C, Chen Y . Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens. 1995; 8(7):768-71. DOI: 10.1016/0895-7061(95)00078-4. View

16.

Sawathiparnich P, Weerakulwattana L, Santiprabhob J, Likitmaskul S . Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS. J Med Assoc Thai. 2006; 88 Suppl 8:S33-7. View

17.

Ciaraldi T, Kettel M, Madar Z, Reichart D, Yen S, Olefsky J . Mechanisms of cellular insulin resistance in human pregnancy. Am J Obstet Gynecol. 1994; 170(2):635-41. DOI: 10.1016/s0002-9378(94)70241-1. View

18.

Kritz-Silverstein D, Barrett-Connor E, Wingard D . The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med. 1989; 321(18):1214-9. DOI: 10.1056/NEJM198911023211802. View

19.

Yilmaz M, Biri A, Karakoc A, Toruner F, Bingol B, Cakir N . The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest. 2006; 28(11):1003-8. DOI: 10.1007/BF03345339. View

20.

Peters R, Kjos S, Xiang A, Buchanan T . Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet. 1996; 347(8996):227-30. DOI: 10.1016/s0140-6736(96)90405-5. View